Selected research
Industry Growth & Trends
Global EPA and DHA Formula Industry Growth and Trends Forecast to 2032
Market perspective
The global EPA and DHA Formula market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for EPA and DHA Formula is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for EPA and DHA Formula is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for EPA and DHA Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of EPA and DHA Formula include Doctor's Nutrition, Efamol, Jarrow Formulas, Lepivits, Metagenics, Nature's Way Products, Now, Perelel and Puori, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global EPA and DHA Formula market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The EPA and DHA Formula market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global EPA and DHA Formula market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to EPA and DHA Formula.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global EPA and DHA Formula market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
EPA and DHA Formula Market by Company
Doctor's Nutrition
Efamol
Jarrow Formulas
Lepivits
Metagenics
Nature's Way Products
Now
Perelel
Puori
Ross J. Barr
Thorne
Youtheory
EPA and DHA Formula Segment by Type
From Plants
From Animals
EPA and DHA Formula Segment by Application
Online Sales
Offline Sales
EPA and DHA Formula Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EPA and DHA Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of EPA and DHA Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EPA and DHA Formula.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of EPA and DHA Formula manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of EPA and DHA Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- From Plants
- From Animals
Applications
- Online Sales
- Offline Sales
Companies covered
- Doctor's Nutrition
- Efamol
- Jarrow Formulas
- Lepivits
- Metagenics
- Nature's Way Products
- Now
- Perelel
- Puori
- Ross J. Barr
- Thorne
- Youtheory
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global EPA and DHA Formula Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global EPA and DHA Formula Sales Estimates and Forecasts (2021-2032)
- 1.3 EPA and DHA Formula Market by Type
- 1.3.1 From Plants
- 1.3.2 From Animals
- 1.4 Global EPA and DHA Formula Market Size by Type
- 1.4.1 Global EPA and DHA Formula Market Size Overview by Type (2021-2032)
- 1.4.2 Global EPA and DHA Formula Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global EPA and DHA Formula Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America EPA and DHA Formula Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe EPA and DHA Formula Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific EPA and DHA Formula Sales Breakdown by Type (2021-2026)
- 1.5.4 South America EPA and DHA Formula Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa EPA and DHA Formula Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 EPA and DHA Formula Industry Trends
- 2.2 EPA and DHA Formula Industry Drivers
- 2.3 EPA and DHA Formula Industry Opportunities and Challenges
- 2.4 EPA and DHA Formula Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by EPA and DHA Formula Revenue (2021-2026)
- 3.2 Global Top Players by EPA and DHA Formula Sales (2021-2026)
- 3.3 Global Top Players by EPA and DHA Formula Price (2021-2026)
- 3.4 Global EPA and DHA Formula Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global EPA and DHA Formula Major Company Production Sites & Headquarters
- 3.6 Global EPA and DHA Formula Company, Product Type & Application
- 3.7 Global EPA and DHA Formula Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global EPA and DHA Formula Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 EPA and DHA Formula Players Market Share by Revenue in 2025
- 3.8.3 2025 EPA and DHA Formula Tier 1, Tier 2, and Tier 3
4 EPA and DHA Formula Regional Status and Outlook
- 4.1 Global EPA and DHA Formula Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global EPA and DHA Formula Historic Market Size by Region
- 4.2.1 Global EPA and DHA Formula Sales in Volume by Region (2021-2026)
- 4.2.2 Global EPA and DHA Formula Sales in Value by Region (2021-2026)
- 4.2.3 Global EPA and DHA Formula Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global EPA and DHA Formula Forecasted Market Size by Region
- 4.3.1 Global EPA and DHA Formula Sales in Volume by Region (2027-2032)
- 4.3.2 Global EPA and DHA Formula Sales in Value by Region (2027-2032)
- 4.3.3 Global EPA and DHA Formula Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 EPA and DHA Formula by Application
- 5.1 EPA and DHA Formula Market by Application
- 5.1.1 Online Sales
- 5.1.2 Offline Sales
- 5.2 Global EPA and DHA Formula Market Size by Application
- 5.2.1 Global EPA and DHA Formula Market Size Overview by Application (2021-2032)
- 5.2.2 Global EPA and DHA Formula Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global EPA and DHA Formula Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America EPA and DHA Formula Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe EPA and DHA Formula Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific EPA and DHA Formula Sales Breakdown by Application (2021-2026)
- 5.3.4 South America EPA and DHA Formula Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa EPA and DHA Formula Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Doctor's Nutrition
- 6.1.1 Doctor's Nutrition Company Information
- 6.1.2 Doctor's Nutrition Business Overview
- 6.1.3 Doctor's Nutrition EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Doctor's Nutrition EPA and DHA Formula Product Portfolio
- 6.1.5 Doctor's Nutrition Recent Developments
- 6.2 Efamol
- 6.2.1 Efamol Company Information
- 6.2.2 Efamol Business Overview
- 6.2.3 Efamol EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Efamol EPA and DHA Formula Product Portfolio
- 6.2.5 Efamol Recent Developments
- 6.3 Jarrow Formulas
- 6.3.1 Jarrow Formulas Company Information
- 6.3.2 Jarrow Formulas Business Overview
- 6.3.3 Jarrow Formulas EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Jarrow Formulas EPA and DHA Formula Product Portfolio
- 6.3.5 Jarrow Formulas Recent Developments
- 6.4 Lepivits
- 6.4.1 Lepivits Company Information
- 6.4.2 Lepivits Business Overview
- 6.4.3 Lepivits EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Lepivits EPA and DHA Formula Product Portfolio
- 6.4.5 Lepivits Recent Developments
- 6.5 Metagenics
- 6.5.1 Metagenics Company Information
- 6.5.2 Metagenics Business Overview
- 6.5.3 Metagenics EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Metagenics EPA and DHA Formula Product Portfolio
- 6.5.5 Metagenics Recent Developments
- 6.6 Nature's Way Products
- 6.6.1 Nature's Way Products Company Information
- 6.6.2 Nature's Way Products Business Overview
- 6.6.3 Nature's Way Products EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Nature's Way Products EPA and DHA Formula Product Portfolio
- 6.6.5 Nature's Way Products Recent Developments
- 6.7 Now
- 6.7.1 Now Company Information
- 6.7.2 Now Business Overview
- 6.7.3 Now EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Now EPA and DHA Formula Product Portfolio
- 6.7.5 Now Recent Developments
- 6.8 Perelel
- 6.8.1 Perelel Company Information
- 6.8.2 Perelel Business Overview
- 6.8.3 Perelel EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Perelel EPA and DHA Formula Product Portfolio
- 6.8.5 Perelel Recent Developments
- 6.9 Puori
- 6.9.1 Puori Company Information
- 6.9.2 Puori Business Overview
- 6.9.3 Puori EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Puori EPA and DHA Formula Product Portfolio
- 6.9.5 Puori Recent Developments
- 6.10 Ross J. Barr
- 6.10.1 Ross J. Barr Company Information
- 6.10.2 Ross J. Barr Business Overview
- 6.10.3 Ross J. Barr EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Ross J. Barr EPA and DHA Formula Product Portfolio
- 6.10.5 Ross J. Barr Recent Developments
- 6.11 Thorne
- 6.11.1 Thorne Company Information
- 6.11.2 Thorne Business Overview
- 6.11.3 Thorne EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Thorne EPA and DHA Formula Product Portfolio
- 6.11.5 Thorne Recent Developments
- 6.12 Youtheory
- 6.12.1 Youtheory Company Information
- 6.12.2 Youtheory Business Overview
- 6.12.3 Youtheory EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Youtheory EPA and DHA Formula Product Portfolio
- 6.12.5 Youtheory Recent Developments
7 North America by Country
- 7.1 North America EPA and DHA Formula Sales by Country
- 7.1.1 North America EPA and DHA Formula Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America EPA and DHA Formula Sales by Country (2021-2026)
- 7.1.3 North America EPA and DHA Formula Sales Forecast by Country (2027-2032)
- 7.2 North America EPA and DHA Formula Market Size by Country
- 7.2.1 North America EPA and DHA Formula Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America EPA and DHA Formula Market Size by Country (2021-2026)
- 7.2.3 North America EPA and DHA Formula Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe EPA and DHA Formula Sales by Country
- 8.1.1 Europe EPA and DHA Formula Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe EPA and DHA Formula Sales by Country (2021-2026)
- 8.1.3 Europe EPA and DHA Formula Sales Forecast by Country (2027-2032)
- 8.2 Europe EPA and DHA Formula Market Size by Country
- 8.2.1 Europe EPA and DHA Formula Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe EPA and DHA Formula Market Size by Country (2021-2026)
- 8.2.3 Europe EPA and DHA Formula Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific EPA and DHA Formula Sales by Country
- 9.1.1 Asia-Pacific EPA and DHA Formula Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific EPA and DHA Formula Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific EPA and DHA Formula Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific EPA and DHA Formula Market Size by Country
- 9.2.1 Asia-Pacific EPA and DHA Formula Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific EPA and DHA Formula Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific EPA and DHA Formula Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America EPA and DHA Formula Sales by Country
- 10.1.1 South America EPA and DHA Formula Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America EPA and DHA Formula Sales by Country (2021-2026)
- 10.1.3 South America EPA and DHA Formula Sales Forecast by Country (2027-2032)
- 10.2 South America EPA and DHA Formula Market Size by Country
- 10.2.1 South America EPA and DHA Formula Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America EPA and DHA Formula Market Size by Country (2021-2026)
- 10.2.3 South America EPA and DHA Formula Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa EPA and DHA Formula Sales by Country
- 11.1.1 Middle East and Africa EPA and DHA Formula Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa EPA and DHA Formula Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa EPA and DHA Formula Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa EPA and DHA Formula Market Size by Country
- 11.2.1 Middle East and Africa EPA and DHA Formula Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa EPA and DHA Formula Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa EPA and DHA Formula Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 EPA and DHA Formula Value Chain Analysis
- 12.1.1 EPA and DHA Formula Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 EPA and DHA Formula Production Mode & Process
- 12.2 EPA and DHA Formula Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 EPA and DHA Formula Distributors
- 12.2.3 EPA and DHA Formula Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst